BXLT
Baxalta Incorporated
Biopharmaceutical company focused on hematology, immunology, and genetic therapies, spun off from Baxter International
CUSIP: 07177M103HealthcareUS1 holder
Total Value
$129.03M
Total Shares
4.09M
Net Share Change
+4.09M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Pzena Investment Management
$129.03M4.09M sharesNEW